After the Space Station: Why Medicine Should Pay Attention to Commercial Orbit
NASA has opened the contest for commercial space stations. A physician and investor on why orbit matters to medicine, and what to watch.
5 min read
NASA has formally opened the competition for the stations that will follow the International Space Station. Companies have until 8 December to propose orbital "destinations" and the transport to reach them, and awards are expected next spring. It reads like an aerospace story. I think it is also a medical one.
Why a cardiologist cares about orbit
For twenty-five years my work has been about the heart under stress. Spaceflight is a long, controlled experiment in exactly that: fluid shifts toward the head, a heart that no longer works against gravity, bones and muscles that lose load. What we have learned from astronauts has already informed how we think about bed rest, deconditioning and recovery on Earth.
A handful of government laboratories can only run so many of those studies. A market of commercial stations, which the new contracts are meant to support for research, technology and crew training, could run many more, for more paying customers, with more varied crews.
Where the opportunity is, and where it is not
As an investor I try to separate the durable from the exciting.
- Durable: the instruments, monitoring and data systems that keep people healthy far from a hospital. The same tools serve remote and rural care on the ground.
- Durable: testing that shows equipment survives radiation and vibration. Every new station and module needs it.
- Exciting, but unproven: manufacturing drugs or tissues in microgravity at a commercial scale. The science is promising; the economics are not yet shown.
Space investment is on course for a record year. Record years invite overconfidence. The questions I would ask are the same ones I ask of any medical technology: what does it measure, who pays for it, and would it still be useful if the timeline slipped by five years?
What to watch
The awards next spring will show how many stations NASA expects the market to support, and how much of the research agenda is set aside for life sciences. For physicians, the useful step now is simpler: follow the human-health work coming out of orbit, because some of it will be in our clinics sooner than the stations themselves.
Sources: NewSpace Economy, "NASA opens its commercial space station contract competition" (22 Oct 2026); NASA, Commercial LEO Destinations solicitation; Bloomberg, "Space investment to top $100 billion in 2026" (13 Oct 2026).
About the author. Irfan Siddiqui is a physician, entrepreneur and investor with more than twenty-five years in medicine. He founded Impero Capital Holdings, a single-family office, and is the physician behind Regenerative Health & Wellness (concierge medicine) and Expert Medical Advisors & Consultants (independent medical review). Read his full biography.